Improving product quality and productivity of bispecific molecules through the application of continuous perfusion principles. (13th February 2020)

• Record Type: Journal Article
• Authors: Gomez, Natalia; Lull, Jonathan; Yang, Xiaorui; Wang, Yan; Zhang, Xin; Wieczorek, Agatha; Harrahy, John; Pritchard, Mike; Cano, Diandra Martinez; Shearer, Michael; Goudar, Chetan
• Is Part Of: Biotechnology progress. Volume 36:Number 4(2020)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-02-13
• Subjects: bispecific -- productivity -- product‐related impurities; Biotechnology -- Periodicals; Food industry and trade -- Periodicals; Bioengineering -- Periodicals; 660.6
• DOI: 10.1002/btpr.2973
• Languages: English
• ISSNs: 8756-7938

Abstract

Abstract: Bispecific protein scaffolds can be more complex than traditional monoclonal antibodies (MAbs) because two different sites/domains for epitope binding are needed. Because of this increased molecular complexity, bispecific molecules are difficult to express and can be more prone to physical and chemical degradation compared to MAbs, leading to higher levels of protein aggregates, clipped species, or modified residues in cell culture. In this study, we investigated cell culture performance for the production of three types of bispecific molecules developed at Amgen. In particular, we cultured a total of six CHO cell lines in both an approximately 12‐day fed‐batch process and an approximately 40‐day high‐density perfusion process. Harvested cell culture fluid from each process was purified and analyzed for product quality attributes including aggregate levels, clipped species, charge variants, individual amino acid modifications and host cell protein (HCP) content. Our studies showed that in average, the intensified perfusion process increased 15‐fold the integrated viable cell density and the total harvested product (and fivefold the daily volumetric productivity) compared to fed‐batch. Furthermore, bispecific product quality improved in perfusion culture (as analyzed in affinity‐capture pools) with reduction in levels of aggregates (up to 72% decrease), clipped species (up to 75% decrease), acidic variants (up to 76% decrease), deamidated/isomerized species in complementarity‐determining regions, and HCP (up to 84% decrease). In summary, the intensified perfusion process exhibited better productivity and product quality, highlighting the potential to use it as part of a continuous manufacturing process for bispecific scaffolds.